Compare LSAK & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LSAK | AXGN |
|---|---|---|
| Founded | 1997 | N/A |
| Country | South Africa | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 328.4M | 1.4B |
| IPO Year | N/A | N/A |
| Metric | LSAK | AXGN |
|---|---|---|
| Price | $4.33 | $32.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $33.67 |
| AVG Volume (30 Days) | 30.0K | ★ 901.7K |
| Earning Date | 02-04-2026 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $677,582,000.00 | $214,709,000.00 |
| Revenue This Year | $11.97 | $21.57 |
| Revenue Next Year | $9.14 | $15.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 16.48 | ★ 18.72 |
| 52 Week Low | $3.39 | $9.22 |
| 52 Week High | $5.58 | $34.24 |
| Indicator | LSAK | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 63.56 | 67.91 |
| Support Level | $4.27 | $28.98 |
| Resistance Level | $4.49 | $33.15 |
| Average True Range (ATR) | 0.17 | 1.54 |
| MACD | 0.02 | -0.07 |
| Stochastic Oscillator | 88.00 | 74.60 |
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.